Menopause and Frozen Shoulder: The Hormone Link Behind a Painful Midlife Condition

The first clue is often a bra clasp. One morning the hand that has fastened it for thirty years simply will not reach, and the shoulder answers with a hot, deep ache that has no story behind it: no fall, no awkward lift, nothing. For a great many women that morning arrives somewhere between 45 and 55, the same window in which periods become erratic and nights turn sweaty.

As of March 2026, searches for menopause frozen shoulder are climbing fast, pushed by viral posts from women who noticed the coincidence and by a 2024 medical review that grouped joint pain, tendon trouble and frozen shoulder under a proposed label, the musculoskeletal syndrome of menopause. The clips are persuasive. The science is more tentative, and more interesting, than a thirty-second video allows.

This piece sets out what frozen shoulder is, why midlife women get it so often, how strong the hormone evidence really is, and what reliably helps.

Why is menopause frozen shoulder suddenly everywhere?

Two things collided. The first is simple demographics: millions of women born in the late 1960s and 1970s are moving through perimenopause at once, and they talk about it online with a candour earlier generations never had. The second is a shift in medical language. Until recently, menopause clinics focused on hot flushes, sleep and mood, while shoulder complaints went to orthopaedic or physiotherapy clinics. The two conversations rarely met.

Then, in 2024, a group of menopause and orthopaedic specialists published a review proposing the term musculoskeletal syndrome of menopause: a cluster of joint aches, tendon injuries, muscle loss and frozen shoulder that seems to spike as estrogen falls. The review drew on existing observational studies rather than new trials, but it gave women a name for something they had already noticed, and names travel fast on social media.

A third ingredient followed. Clips began claiming that hormone therapy prevents or fixes frozen shoulder, and that doctors are missing a hormonal condition. That claim leans on a single small analysis presented at a 2023 menopause conference, which found women taking hormone therapy had somewhat lower odds of frozen shoulder, a difference that did not reach statistical significance once other factors were accounted for.

So the trend rests on a genuine clinical pattern, a plausible biological mechanism and a thin layer of evidence stretched further than it can bear. Each of those three layers deserves separate treatment, which is what the rest of this article does. The pattern is real. The mechanism is reasonable. The treatment claims are, for now, ahead of the data.

What is frozen shoulder (adhesive capsulitis), exactly?

The shoulder is a ball-and-socket joint wrapped in a sleeve of connective tissue called the joint capsule. In frozen shoulder, known medically as adhesive capsulitis, that capsule becomes inflamed, thickens and tightens, so the ball can no longer glide freely in its socket. Imagine a leather glove left out in the rain and then dried by a radiator: the material shrinks and stiffens, and the hand inside loses room to move.

Two features set frozen shoulder apart from the many other causes of a sore shoulder. The first is that movement is lost in every direction, not just one. Reaching overhead, behind the back and out to the side all become restricted. The second is that someone else cannot move the arm for you either. If a clinician gently lifts your relaxed arm and it stops at the same point you reach on your own, the problem lies in the capsule, not the muscles or tendons.

Mayo Clinic and Cleveland Clinic both describe the condition as affecting roughly 2 to 5 percent of adults over a lifetime, with the peak between ages 40 and 60. It is rare before 40 and uncommon after 70. It usually affects one shoulder, and when it does strike the other side, that tends to happen years later rather than at the same time. Having it twice in the same shoulder is unusual.

Frozen shoulder can appear for no identifiable reason, which doctors call primary or idiopathic, or follow a period when the arm was kept still, after a fracture, breast surgery, a stroke or a long illness. The idiopathic form is the one that so often arrives in midlife, and it is the form the menopause debate is about.

The frozen shoulder stages: freezing, frozen and thawing

Frozen shoulder moves through three recognisable phases, and knowing which one you are in changes what helps. The names are blunt but useful.

The freezing stage is the painful one. Over weeks the shoulder aches at rest, flares with sudden movement and is often worst at night, so that rolling onto that side wakes you. Range of motion shrinks steadily. Cleveland Clinic puts this phase at anywhere from six weeks to nine months. Because pain dominates, aggressive stretching here tends to backfire.

The frozen stage follows. Pain usually eases, sometimes dramatically, but stiffness peaks. Everyday tasks such as washing hair, reaching a back pocket or fastening a seat belt become awkward workarounds involving the other arm. This phase typically lasts four to twelve months. Stretching and strengthening are better tolerated now and are the main work of recovery.

Thawing is the slow return of movement. It can take anywhere from five months to two years, and improvement is often noticed in retrospect rather than week by week.

Put together, Mayo Clinic describes a total course of one to three years. That figure deserves a pause. A woman whose shoulder freezes at 49 may still be thawing at 51, right through the most turbulent years of the menopause transition, which makes it easy to assume the hormones are driving the shoulder when the two may simply be running on parallel timelines.

Most people regain the large majority of their movement without surgery. A minority are left with some residual stiffness, usually mild, usually in the extremes of reach rather than in daily tasks.

Why does frozen shoulder hit women in perimenopause and midlife?

Frozen shoulder is more common in women than men, and the sex difference is concentrated in exactly the decade when estrogen declines. That overlap is the whole basis of the current debate, so it is worth being precise about the timeline.

Perimenopause is the stretch of years before periods stop, when ovarian hormone production becomes erratic and then falls. The NHS notes it commonly begins in the mid-40s, and menopause itself, defined as 12 months without a period, arrives on average at 51. Estrogen does not fall smoothly through this window. It swings, sometimes higher than before, then drops in uneven steps, with the steepest decline in the two or three years around the final period.

Frozen shoulder incidence, meanwhile, rises sharply after 40, peaks in the 50s and tails off after 60. Lay the two curves on top of each other and the resemblance is striking. Correlation of this kind is a reasonable prompt for a hypothesis. It is not proof. Several other midlife changes track the same years: type 2 diabetes becomes more common, thyroid disorders peak in women in their 40s and 50s, body weight drifts upward, and physical activity often drops. Each of those is independently associated with frozen shoulder.

There is also a selection effect. Women in midlife see doctors more often, partly because of menopause itself, so a stiff shoulder is more likely to be noticed and recorded.

None of this rules out a hormonal contribution. It means the honest statement is narrower than the viral version: frozen shoulder clusters in the menopausal years, several plausible explanations overlap, and estrogen is one candidate among them rather than the proven culprit.

What changed recently

The underlying biology has not changed. What has changed is how clinicians and patients talk about it, and a few dated developments explain the surge.

In September 2023, researchers presented an observational analysis at an annual menopause society meeting examining women aged 45 to 60 with a shoulder diagnosis. Those using menopausal hormone therapy had lower odds of frozen shoulder, but the sample was small and the association lost statistical significance after adjustment. The authors themselves called for larger studies. Social media did not include that caveat.

In 2024, a review article in a menopause journal proposed the umbrella term musculoskeletal syndrome of menopause, estimating from existing literature that more than 70 percent of women experience musculoskeletal symptoms during the transition and roughly a quarter are disabled by them. The paper was a synthesis of observational data and expert opinion, explicitly intended to spur research rather than to establish a new diagnosis.

Patient guidance has also been updated. The NHS frozen shoulder page now states plainly that the condition can take months or years to settle and sets out a stepped approach: painkillers, physiotherapy, steroid injections and, when needed, hospital procedures. Cleveland Clinic’s current page lists diabetes, thyroid disease and recent immobilisation as the leading risk factors and notes that most people recover without surgery.

What has not changed is the treatment evidence base. A large UK randomised trial published in 2020 compared physiotherapy with steroid injection, manipulation under anaesthesia and arthroscopic capsular release, and found all three produced substantial improvement at 12 months with no clear winner. No randomised trial of hormone therapy for frozen shoulder has been published as of March 2026.

How could estrogen affect the shoulder capsule?

The mechanism matters, because a plausible pathway is what turns a coincidence into a hypothesis worth testing. Here the biology is genuinely suggestive.

Estrogen receptors, the docking sites that let the hormone act on a cell, are present in tendons, ligaments and the fibroblasts that build and maintain connective tissue. A fibroblast is the cell that lays down collagen, the rope-like protein that gives the joint capsule its strength and its stretch. Laboratory and animal studies show estrogen influences how much collagen fibroblasts make, how it is cross-linked and how quickly damaged tissue is remodelled. Lower estrogen is associated with stiffer, less elastic collagen in several tissues, including skin, which is why skin loses its spring after menopause.

Frozen shoulder is, at its core, a disorder of excess collagen and scarring in the capsule, driven by inflammation and overactive fibroblasts. If estrogen normally keeps that process in check, its withdrawal could tip a vulnerable shoulder toward fibrosis. Estrogen also has anti-inflammatory effects on several immune signalling molecules, and inflammation is prominent in the freezing stage.

That is the theory. Its weak points are worth stating. Men get frozen shoulder too, with no estrogen collapse. Women with diabetes get it at several times the rate of women without, regardless of hormone status, which points to sugar-related collagen changes as a stronger driver. And the hormonal swings of perimenopause are brief compared with the one-to-three-year course of a frozen shoulder.

The fair summary is that estrogen withdrawal is a biologically credible contributor to the midlife peak, supported by cell and tissue studies, but no human study has yet shown that estrogen levels predict who develops frozen shoulder or how fast it recovers.

Menopause frozen shoulder: what the evidence actually says

Medical evidence comes in grades. Randomised controlled trials, where people are allocated by chance to a treatment or a comparison, sit at the top because they remove most bias. Observational studies, which watch what happens to people who happened to make different choices, sit lower, because the groups differ in ways that are hard to measure. Expert opinion and laboratory work sit lower still. Here is how the menopause frozen shoulder story stacks up against that ladder.

Claim	Type of evidence	Strength
Frozen shoulder peaks in women aged 40–60	Large observational datasets	Strong and consistent
Diabetes and thyroid disease raise risk	Multiple observational studies	Strong
Estrogen affects collagen and fibroblasts	Laboratory and animal studies	Moderate for mechanism, untested in human shoulders
Hormone therapy lowers frozen shoulder risk	One small observational analysis, 2023	Weak; not statistically significant after adjustment
Hormone therapy treats established frozen shoulder	No published trials	None
Physiotherapy, steroid injection and capsular release improve outcomes	Randomised trials	Strong

Read down the right-hand column and the pattern is clear. The parts of the story that are well established are the epidemiology and the conventional treatments. The hormonal link is a credible hypothesis resting on mechanism and timing. The treatment claim, that estrogen will prevent or reverse a frozen shoulder, has no trial behind it at all.

That is not a dismissal. Many real associations began as a pattern noticed by patients before being confirmed by research. It simply means that, today, a clinician cannot honestly tell a woman that her hormones caused her shoulder, nor that correcting them will thaw it.

HRT and frozen shoulder: can hormone therapy prevent or treat it?

This is the question behind most of the searches, so it deserves a direct answer. Menopausal hormone therapy, often shortened to HRT or MHT, replaces estrogen, usually with a progestogen for women who still have a uterus, to relieve menopausal symptoms. Mayo Clinic lists its approved uses as hot flushes, night sweats, vaginal symptoms and prevention of bone loss in women at risk. Frozen shoulder is not among them anywhere in the world.

The only human data specific to this question is the 2023 observational analysis described earlier. Women on hormone therapy appeared somewhat less likely to have frozen shoulder, but the confidence interval, the statistical range within which the true effect probably lies, was wide enough to include no effect at all. Observational studies of hormone therapy are also prone to a well-known problem: women who choose and are prescribed HRT tend to be healthier, leaner and less likely to have diabetes than those who are not, and each of those factors lowers frozen shoulder risk on its own.

No trial has tested whether starting estrogen speeds recovery from an existing frozen shoulder, and none is registered as of March 2026.

What does this mean in practice? For a woman already weighing hormone therapy for hot flushes, poor sleep or bone protection, a frozen shoulder does not change the balance of established benefits and risks, which include small increases in breast cancer, blood clot and stroke risk depending on the type, dose and timing. For a woman whose only symptom is the shoulder, there is no evidence to support starting hormones for that reason.

The decision to start, continue, adjust or stop hormone therapy belongs with the prescribing clinician, who can weigh the whole picture. A sore shoulder should prompt that conversation, not replace it.

Diabetes, thyroid disease and the risk factors that matter more

If the hormone link is the headline, diabetes is the story buried on page six that probably matters more. Mayo Clinic and Cleveland Clinic both identify it as the single strongest risk factor. Lifetime risk of frozen shoulder in people with diabetes is estimated at 10 to 20 percent, several times the general population figure, and the condition tends to be more severe and slower to resolve. Both type 1 and type 2 are implicated.

The likely mechanism is instructive because it mirrors the estrogen theory. Persistently high blood sugar attaches glucose molecules to collagen, forming advanced glycation end products, cross-links that make connective tissue stiffer and more prone to scarring. Midlife is precisely when type 2 diabetes and prediabetes become common, and many women are unaware they have either.

Thyroid disease, both overactive and underactive, is the next most consistent association, and thyroid disorders peak in women during the same decades as menopause. Cleveland Clinic also lists Parkinson’s disease, heart disease and a previous stroke.

Immobilisation is the other big one. Any reason the arm stays still for weeks, a wrist fracture in a sling, recovery from breast or chest surgery, a long hospital stay, can set the capsule tightening. Women who have had breast cancer treatment are at particular risk because surgery, radiotherapy and protective guarding of the arm all combine.

The practical point is this. A midlife woman with a new frozen shoulder gains more from a blood glucose test and a thyroid check than from speculation about estrogen. Both are routine, both identify treatable conditions, and both are recommended by mainstream sources when frozen shoulder appears without an obvious cause. The hormone question can be asked alongside, not instead.

How is frozen shoulder diagnosed, and what else could it be?

Frozen shoulder is a clinical diagnosis, meaning it is made by history and examination rather than a scan. The clinician asks when the pain began, whether it wakes you, and what you can no longer reach. Then they move the arm.

The defining test is passive range of motion: the clinician lifts and rotates your relaxed arm. In frozen shoulder, outward rotation with the elbow tucked at the side is usually the first and most restricted movement, and the arm stops at the same point whether you move it or they do. That distinguishes it from a rotator cuff problem, where you may struggle to lift the arm yourself because of weakness or pain, but someone else can raise it fully.

Imaging is used mainly to exclude other causes. An X-ray looks for osteoarthritis of the shoulder joint, which also causes global stiffness but shows bone changes, and for calcium deposits in the tendons. MedlinePlus notes that MRI or ultrasound may be ordered if a tendon tear is suspected, since tears and frozen shoulder can coexist, particularly after an injury.

Several conditions overlap in midlife and are worth naming. Rotator cuff tendinopathy produces pain on reaching but preserves passive movement. Shoulder osteoarthritis causes stiffness with grinding and shows on X-ray. Polymyalgia rheumatica, an inflammatory condition of people over 50, causes stiffness in both shoulders and the hips at once, with marked morning stiffness and raised inflammatory markers on a blood test. Referred pain from the neck follows the nerve path down the arm and often includes tingling.

Because the treatment for each differs, a confident diagnosis is worth getting early, ideally in the freezing stage when pain control and gentle movement can prevent unnecessary loss of range.

Which treatments actually help a frozen shoulder?

The good news in this story is that frozen shoulder treatment is well studied, and most of it works. The NHS describes a stepped approach, and the randomised evidence broadly supports it.

Pain relief comes first. Over-the-counter analgesics and anti-inflammatory medicines are commonly used in the freezing stage to allow sleep and gentle movement. Which medicine suits an individual, and for how long, depends on their other conditions and is a decision for a pharmacist or doctor.

Physiotherapy is the backbone. A physiotherapist tailors stretching and later strengthening to the stage you are in, respecting pain in the freezing phase and pushing range in the frozen phase. Supervised programmes outperform unguided effort in most studies, largely because people stretch too hard early and too little late.

Corticosteroid injection into the joint has the best trial evidence for rapid relief. Randomised trials show meaningful reductions in pain and improvements in movement within the first six to twelve weeks, with the advantage over physiotherapy alone fading by about a year. Injections are most useful in the painful early phase.

Hydrodilatation, in which a clinician injects fluid under pressure to stretch the capsule, and manipulation under anaesthesia, in which the shoulder is moved through its range while you are asleep, are options for stubborn stiffness. Arthroscopic capsular release, keyhole surgery to cut the thickened capsule, is reserved for cases that fail to thaw. The large UK trial that compared these approaches found all improved function substantially at 12 months, with surgery offering a small edge that the authors judged clinically modest against its risks.

Cleveland Clinic estimates that up to 90 percent of people recover without surgery. Patience is, unglamorously, part of the treatment.

Frozen shoulder exercises: what is safe and what to avoid

Exercise is the one part of frozen shoulder care that sits in your own hands, and the right exercise at the wrong time can set you back. A few principles, drawn from physiotherapy guidance on NHS and Harvard Health pages, keep it safe.

Match effort to stage. During the freezing phase, when pain leads, the aim is to maintain what movement you have, not to reclaim lost range. Pendulum swings, letting the arm hang and gently circle, and assisted lifts using the good arm or a stick are usually tolerated. Pushing into sharp pain in this phase tends to inflame the capsule further and worsen night pain.

Once pain settles into the frozen phase, stretching becomes the priority. Useful movements include:

• Walking the fingers up a wall, both facing it and side-on, and holding at the top.
• Towel stretches behind the back, pulling the affected arm gently upward with the other hand.
• Cross-body stretches, drawing the arm across the chest and holding.
• Outward rotation with the elbow tucked at the side, using a doorframe or stick for leverage.

Hold stretches for 15 to 30 seconds, aim for a strong pull rather than pain, and repeat several times a day; little and often beats one heroic session. Heat before stretching loosens tissue; a cold pack afterwards can calm any flare.

Strengthening the muscles around the shoulder blade and rotator cuff comes last, in the thawing phase, to restore control as range returns.

Avoid heavy overhead lifting, sudden reaching behind you and sleeping on the affected side until pain allows. And be wary of online programmes promising to break up a frozen shoulder in days. The capsule remodels on its own slow schedule, and a physiotherapist who sees how your shoulder actually moves remains the best guide to progression.

Common myths about menopause and frozen shoulder

Viral health content thrives on clean cause-and-effect stories. Frozen shoulder resists them. Here are the claims circulating most widely, and what the evidence supports.

Myth: menopause causes frozen shoulder. The honest version is that frozen shoulder clusters in the menopausal years and falling estrogen is a credible contributor. Men develop it too, women with diabetes develop it far more often regardless of hormone status, and no study has shown estrogen levels predict who gets it.

Myth: hormone therapy prevents it. One small observational analysis found lower odds in women on hormone therapy, not statistically significant after adjustment. That is a reason to study the question, not a basis for prescribing. Hormone therapy has established uses and established risks; frozen shoulder is not currently among its indications.

Myth: starting estrogen will thaw a frozen shoulder. No trial has tested this. Frozen shoulder follows a one-to-three-year course and improves in most people, so any treatment started along the way will seem to work. That is why randomised comparisons exist.

Myth: doctors are ignoring a hormonal condition. Frozen shoulder is a well-recognised diagnosis with evidence-based treatments. What is new is the research interest in why it peaks in midlife women, and that interest is now mainstream rather than fringe.

Myth: you have to push through the pain to free it. Forcing a shoulder in the freezing stage usually makes pain and inflammation worse. Stage-matched exercise is the approach supported by physiotherapy evidence.

Myth: it never fully recovers. Most people regain the large majority of movement. A minority keep mild residual stiffness, more often those with diabetes or very prolonged courses.

The thread running through these corrections is the same: the pattern is real, the mechanism is plausible, and the certainty is borrowed.

When to see a doctor

A stiff, aching shoulder in midlife is common and usually not dangerous, but a few situations should prompt an appointment rather than a wait-and-see approach, and some need urgent attention.

Book a routine appointment if shoulder pain has lasted more than two or three weeks without an obvious cause, if you are losing range of movement, if pain regularly wakes you at night, or if you cannot do ordinary tasks such as dressing or reaching a shelf. Early diagnosis matters: pain control and the right exercises in the freezing stage can prevent needless loss of range, and a glucose and thyroid check at the same visit catches the risk factors that are actually treatable.

Tell your doctor if you have diabetes, thyroid disease, a history of breast cancer treatment, or recent surgery or immobilisation of the arm, since these change both the likelihood of frozen shoulder and the way it is managed.

Seek urgent care, the same day, if any of the following apply:

• Shoulder pain that began suddenly with a fall or injury, with visible deformity or an inability to move the arm at all.
• A hot, red, swollen joint, especially with fever, which can signal infection.
• Shoulder or arm pain accompanied by chest pressure, breathlessness, sweating, nausea or pain spreading to the jaw, which can be a heart attack, particularly in women, whose symptoms are often less typical.
• Numbness, weakness or pins and needles in the hand or arm, or pain that follows a clear path from the neck.
• Unexplained weight loss or night sweats alongside bone pain.

If you are taking or considering menopausal hormone therapy, raise the shoulder with the clinician who prescribes it. Do not start, stop or change any hormone treatment on your own in response to joint symptoms; the risks and benefits are individual, and the shoulder is one part of a larger conversation.

Frequently asked questions

Can you get frozen shoulder in perimenopause, before periods stop?

Yes. Perimenopause, the years of fluctuating hormones before the final period, usually begins in the mid-40s, which is exactly when frozen shoulder incidence starts to climb. Many women develop it while still having irregular periods. Whether the hormonal swings themselves trigger it is unproven, but the timing overlap is real and worth mentioning to your doctor alongside other symptoms.

Does low estrogen cause frozen shoulder?

It has not been shown to. Estrogen influences collagen and inflammation in connective tissue, and estrogen receptors exist in tendons and ligaments, so a contribution is biologically plausible. But no human study has demonstrated that estrogen levels predict who develops frozen shoulder. Diabetes, thyroid disease and immobilisation of the arm remain the proven risk factors.

Will HRT fix my frozen shoulder?

There is no evidence that it will. No trial has tested hormone therapy for established frozen shoulder, and the single observational study on prevention found a non-significant association. Hormone therapy has approved uses for hot flushes, night sweats and bone protection, with its own risks; whether it suits you is a decision for your prescribing clinician, not something to start for a shoulder alone.

What are the frozen shoulder stages and how long does each last?

The freezing stage, dominated by pain and growing stiffness, lasts roughly six weeks to nine months. The frozen stage, when pain eases but stiffness peaks, lasts about four to twelve months. The thawing stage, when movement gradually returns, can take five months to two years. The whole course typically spans one to three years, longer in people with diabetes.

Why is frozen shoulder more common in women?

The reasons are not fully understood. Women are more likely to have thyroid disease, which raises risk, and the female peak coincides with the menopause transition, prompting the estrogen hypothesis. Differences in connective tissue, immune responses and healthcare use may also contribute. The sex difference is well documented in large observational datasets; the explanation remains open.

Is frozen shoulder linked to diabetes?

Strongly. People with type 1 or type 2 diabetes have an estimated 10 to 20 percent lifetime risk of frozen shoulder, several times the general population, and their cases tend to be more severe and slower to resolve. High blood sugar stiffens collagen through glycation. A new frozen shoulder without obvious cause is a sensible prompt for a blood glucose test.

Which frozen shoulder exercises are safe at home?

In the painful freezing stage, pendulum swings and gentle assisted lifts are usually tolerated. Once pain settles, wall climbs with the fingers, towel stretches behind the back, cross-body stretches and outward rotation with the elbow tucked at the side help restore range. Stretch to a strong pull rather than sharp pain, several times daily, and let a physiotherapist guide progression.

Do steroid injections work for frozen shoulder?

Randomised trials show corticosteroid injection into the joint reduces pain and improves movement more than physiotherapy alone over the first six to twelve weeks, with the difference fading by about a year. It is most useful in the painful early phase. Whether an injection is appropriate, and how many, is a decision for the treating clinician based on your overall health.

Does frozen shoulder go away on its own?

In most people, largely yes, but slowly. The natural course runs one to three years, and the majority regain most of their movement without surgery. Treatment aims to control pain, shorten the course and protect range in the meantime. A minority are left with mild residual stiffness, more often those with diabetes or a very prolonged course.

Can frozen shoulder come back or affect the other shoulder?

Recurrence in the same shoulder is uncommon. The other shoulder is affected in a minority of people, usually years later rather than at the same time. Having diabetes or thyroid disease raises the chance of a second episode, which is another reason those conditions are worth identifying and managing when a first frozen shoulder appears.

References

• NHS: Frozen shoulder
• MedlinePlus: Frozen shoulder
• NHS: Menopause

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.